What is Bio-Techne's expected EPS for Q4 2026?

Analysts expect Bio-Techne (TECH) to report consensus EPS of approximately $0.52 for Q4 2026. Estimates range from $0.51 to $0.53.

What revenue do analysts expect for Bio-Techne in Q4 2026?

The consensus revenue forecast for Bio-Techne (TECH) in Q4 2026 is approximately $315M. Forecasts range from $312M to $318M.

How many analysts cover Bio-Techne?

8 analysts contribute to the Bio-Techne (TECH) Q4 2026 consensus estimate.

Has Bio-Techne beaten earnings estimates recently?

Bio-Techne beat analyst EPS estimates in 0 of the last 1 quarter. Bio-Techne beat revenue estimates in 0 of 1. In the most recent quarter (Q3 2026), Bio-Techne EPS missed by 0.8% and revenue missed by 1.5%.

When does Bio-Techne report Q4 2026 earnings?

Bio-Techne (TECH) is expected to report Q4 2026 earnings on August 5, 2026 before market open.

TECH Q4 2026 earnings estimate

Consensus EPS · Q4 2026

$0.52

Consensus revenue · Q4 2026

$314.8M

Analysts

Expected report

Aug 5, 2026

Before open

Upcoming earnings

Locks in 8 days 22 hours · BMO: Locks 8:00 PM ET previous day

Revenue$314.8M$311.6M – $317.9M

EPS$0.52$0.51 – $0.53

What to watch

Analyst ratings: Downgrades trending

Make your prediction

Analyst consensus

Based on estimates from 8 analysts.

Metric	Low	Consensus	High
Revenue	$311.6M	$314.8M	$317.9M
EPS	$0.51	$0.52	$0.53
EBITDA	$92.3M	$93.9M	$97.6M
EBIT	$63.4M	$64.6M	$67.1M
Net income	$80M	$81.5M	$83.1M

Revenue$314.8M
EPS$0.52
EBITDA$93.9M
EBIT$64.6M
Net income$81.5M

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q3 2026	$311.4M	$316.1M	-1.5%	$0.53	$0.53	-0.8%

Q3 2026-1.5%-0.8%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Grade C — Mixed / flat revisions

Metric	Now	30d ago	60d ago	90d ago	30d Δ
Revenue	$308M	$318.1M	—	—	-3.2%
EPS	$0.48	$0.50	—	—	-4.4%

0 revised up (30d)2 revised down (30d)

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Bio-Techne (TECH) Q4 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 0 analysts.

Low: $50.00
Consensus: $66.44
Median: $73.00
High: $79.00
Current: $71.60
Upside: -7.2%

Upside calculated vs most recent trading price of $71.60.

Analyst ratings

Consensus: Buy — based on 26 analyst ratings.

Buy 13Hold 13

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
Jul 9, 2026	RBC Capital	downgrade	Outperform	Sector Perform
Jun 30, 2026	TD Cowen	downgrade	Buy	Hold
Jun 30, 2026	Benchmark	downgrade	Buy	Hold
Jun 29, 2026	Citigroup	downgrade	Buy	Neutral
Jun 26, 2026	William Blair	downgrade	Outperform	Market Perform
Jun 26, 2026	Stephens & Co.	downgrade	Overweight	Equal Weight
Jun 26, 2026	Baird	maintain	Neutral	Neutral
May 7, 2026	Wells Fargo	maintain	Overweight	Overweight
May 7, 2026	Evercore ISI Group	maintain	In Line	In Line
May 7, 2026	Citigroup	maintain	Buy	Buy

Jul 9, 2026RBC CapitalSector Perform
Jun 30, 2026TD CowenHold
Jun 30, 2026BenchmarkHold
Jun 29, 2026CitigroupNeutral
Jun 26, 2026William BlairMarket Perform
Jun 26, 2026Stephens & Co.Equal Weight
Jun 26, 2026BairdNeutral
May 7, 2026Wells FargoOverweight
May 7, 2026Evercore ISI GroupIn Line
May 7, 2026CitigroupBuy

Frequently asked questions

Bio-Techne (TECH) Key Financials

Charts, filings, and peer comparison for every metric

Trains Forecasting

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

TECH Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation